RISI, MARIO
 Distribuzione geografica
Continente #
EU - Europa 60
NA - Nord America 26
AS - Asia 15
Totale 101
Nazione #
IT - Italia 33
US - Stati Uniti d'America 25
IE - Irlanda 14
SG - Singapore 9
DE - Germania 3
NL - Olanda 3
GB - Regno Unito 2
IR - Iran 2
BG - Bulgaria 1
CA - Canada 1
CN - Cina 1
FI - Finlandia 1
GR - Grecia 1
KR - Corea 1
PK - Pakistan 1
SE - Svezia 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 101
Città #
Naples 16
Dublin 14
Santa Clara 12
Singapore 8
Amsterdam 3
Aversa 2
Cercola 2
Florence 2
Munich 2
New York 2
Trecase 2
Athens 1
Beijing 1
Boston 1
Bratislava 1
Bremen 1
Cambridge 1
Chandler 1
Istanbul 1
Kamoke 1
Lappeenranta 1
Miami 1
Milan 1
Napoli 1
Newark 1
Ottawa 1
Princeton 1
Quarto 1
Redwood City 1
Roxbury 1
Seoul 1
Sofia 1
Turin 1
Totale 87
Nome #
Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab 46
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients 24
Efficacy and safety of tixagevimab-cilgavimab (Evusheld®) in people with Multiple Sclerosis on Ocrelizumab: preliminary evidence 15
Vocabulary knowledge as a reliable proxy of cognitive reserve in multiple sclerosis: a validation study 12
MOG-IgG testing strategies in accordance with the 2023 MOGAD criteria: a clinical-laboratory assessment 8
Quality of care provided by Multiple Sclerosis Centers during Covid-19 pandemic: Results of an Italian multicenter patient-centered survey 7
Totale 112
Categoria #
all - tutte 873
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 873


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202211 0 0 1 2 4 0 0 0 0 1 0 3
2022/202320 2 0 1 0 1 1 0 1 10 0 2 2
2023/202439 0 0 4 0 3 2 0 1 14 2 8 5
2024/202542 3 4 4 1 30 0 0 0 0 0 0 0
Totale 112